Skip to main content
Apotea AB logo

Apotea AB — Investor Relations & Filings

Ticker · APOTEA ISIN · SE0023313762 LEI · 6367005D3D7BO6FIEV09 ST Wholesale and retail trade
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-04-29 Interim / Quarterly Rep…
Country SE Sweden
Listing ST APOTEA

About Apotea AB

https://www.apotea.se/

Apotea AB operates as an online-only pharmacy. The company offers a comprehensive range of both prescription and over-the-counter medications for humans and animals. Its extensive catalog also includes thousands of products related to health, beauty, skincare, vitamins, and minerals. Apotea provides pharmaceutical consultation and support via email, phone, and chat. The business model focuses on providing fast deliveries, competitive pricing, and a product assortment that is broader than that of traditional brick-and-mortar pharmacies.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport Q1 2026' which translates to 'Interim Report Q1 2026'. It contains detailed financial data for the first quarter of 2026, including net sales, EBIT, cash flow, investments, financial position, and segment performance. The report includes comprehensive financial statements and management commentary on the quarter's results and outlook. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis.
2026-04-29 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 92% confidence The document is titled “Interim report Q1 2026” and contains detailed financial information for the quarter (net revenue, EBIT, cash flow, balance sheet position, segment commentary, CEO comment, risks, targets, etc.). It presents full interim period statements and in-depth analysis rather than just headline figures, fitting the definition of a comprehensive quarterly report. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-04-29 English
Kallelse till årsstämma i Apotea AB (publ)
AGM Information Classification · 100% confidence The document is a detailed notice (kallelse) for the Annual General Meeting (AGM) of Apotea AB, including information on the meeting date, registration, voting procedures, agenda items, and proposals from the nomination committee. It contains no financial statements or results but focuses on procedural and governance matters related to the AGM. The presence of agenda items such as election of board members, approval of financial statements, and authorization for share issues is typical for an AGM notice. The document is lengthy and comprehensive but does not constitute the actual annual report or financial statements. Therefore, it fits the category of AGM Information (AGM-R).
2026-04-17 Swedish
Notice to annual general meeting in Apotea AB (publ)
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a press release titled “Notice to annual general meeting in Apotea AB (publ)” with full details on how shareholders may attend, vote (including postal voting), proxy arrangements and the proposed AGM agenda and resolutions. It is a convocation and information statement sent to shareholders to solicit votes and outline the meeting proposals rather than the actual meeting materials or the results. This matches the definition of a Proxy Solicitation & Information Statement (Code: PSI).
2026-04-17 English
Annual Report 2025
Annual Report Classification · 100% confidence The document is titled 'Apotea AB (publ) Årsredovisning och hållbarhetsrapport 2025', which translates to 'Annual Report and Sustainability Report 2025'. It contains detailed sections typical of an annual report, including CEO's letter, management discussion, financial highlights, governance report, sustainability report, and full financial statements and notes. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes comprehensive financial data, business strategy, market overview, and sustainability efforts, all consistent with a full annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-17 Swedish
Valberedningens förslag till styrelse i Apotea AB (publ)
Board/Management Information Classification · 85% confidence The document is a nomination committee’s proposal for board members and chair ahead of the Annual General Meeting. It announces intended changes to the board composition (re-elections and new appointments). This fits the definition of a Board/Management Information filing (MANG).
2026-03-31 Swedish

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.